Direct comparison of the effects of first- and second-generation H1 -receptor blockers on motor functions in mice.

IF 1.5 4区 医学 Q4 CHEMISTRY, MEDICINAL
Pharmazie Pub Date : 2025-03-31 DOI:10.1691/ph.2025.5509
K Taguchi, K Tenjin, Y Sakamoto, A Shimada, R Hara, O Iketani, Y Okamoto, Y Enoki, J Kizu, S Hori, K Matsumoto
{"title":"Direct comparison of the effects of first- and second-generation H<sub>1</sub> -receptor blockers on motor functions in mice.","authors":"K Taguchi, K Tenjin, Y Sakamoto, A Shimada, R Hara, O Iketani, Y Okamoto, Y Enoki, J Kizu, S Hori, K Matsumoto","doi":"10.1691/ph.2025.5509","DOIUrl":null,"url":null,"abstract":"<p><p>Histamine H1 receptor (H1R) antagonists are widely used to treat allergic reactions; however, their effects on the central nervous system can impair motor functions. This study investigated the impact of first-generation (diphenhydramine and <i>d</i> -chlorpheniramine) and second-generation (epinastine, ketotifen, bepotastine, and levocetirizine) H1R antagonists on motor functions in mice using activity wheel, balance beam, inclined screen, and rotarod tests. First-generation H1R antagonists significantly impaired motor functions, with diphenhydramine exerting stronger effects than those of <i>d</i> -chlorpheniramine. Among the second-generation agents, bepotastine and levocetirizine had minimal effects on all motor functions, whereas epinastine and ketotifen suppressed spontaneous movement, similar to first-generation H1R antagonists but had little effects on balance, postural stability, and coordinated movement. These findings provide valuable insights into the differential effects of first- and second-generation H1R antagonists on motor functions. These results highlight the importance of understanding individual profiles of H1R antagonists to minimize adverse effects, ensure patient safety, and improve quality of life.</p>","PeriodicalId":20145,"journal":{"name":"Pharmazie","volume":"80 1","pages":"24-28"},"PeriodicalIF":1.5000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmazie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1691/ph.2025.5509","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Histamine H1 receptor (H1R) antagonists are widely used to treat allergic reactions; however, their effects on the central nervous system can impair motor functions. This study investigated the impact of first-generation (diphenhydramine and d -chlorpheniramine) and second-generation (epinastine, ketotifen, bepotastine, and levocetirizine) H1R antagonists on motor functions in mice using activity wheel, balance beam, inclined screen, and rotarod tests. First-generation H1R antagonists significantly impaired motor functions, with diphenhydramine exerting stronger effects than those of d -chlorpheniramine. Among the second-generation agents, bepotastine and levocetirizine had minimal effects on all motor functions, whereas epinastine and ketotifen suppressed spontaneous movement, similar to first-generation H1R antagonists but had little effects on balance, postural stability, and coordinated movement. These findings provide valuable insights into the differential effects of first- and second-generation H1R antagonists on motor functions. These results highlight the importance of understanding individual profiles of H1R antagonists to minimize adverse effects, ensure patient safety, and improve quality of life.

第一代和第二代H1受体阻滞剂对小鼠运动功能影响的直接比较。
组胺H1受体(H1R)拮抗剂被广泛用于治疗过敏反应;然而,它们对中枢神经系统的影响会损害运动功能。本研究通过活动轮、平衡木、斜筛和旋转杆试验研究了第一代(苯海拉明和d-氯苯那敏)和第二代(依匹斯汀、酮替芬、比伯他汀和左西替利嗪)H1R拮抗剂对小鼠运动功能的影响。第一代H1R拮抗剂显著损害运动功能,苯海拉明的作用强于d -氯苯那敏。在第二代药物中,bepotastine和左西替利嗪对所有运动功能的影响最小,而epinastine和酮替芬抑制自发运动,类似于第一代H1R拮抗剂,但对平衡、姿势稳定性和协调运动的影响很小。这些发现为第一代和第二代H1R拮抗剂对运动功能的不同影响提供了有价值的见解。这些结果强调了了解H1R拮抗剂的个体特征对于最大限度地减少不良反应、确保患者安全和提高生活质量的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmazie
Pharmazie 医学-化学综合
CiteScore
3.10
自引率
0.00%
发文量
56
审稿时长
1.2 months
期刊介绍: The journal DiePharmazie publishs reviews, experimental studies, letters to the editor, as well as book reviews. The following fields of pharmacy are covered: Pharmaceutical and medicinal chemistry; Pharmaceutical analysis and drug control; Pharmaceutical technolgy; Biopharmacy (biopharmaceutics, pharmacokinetics, biotransformation); Experimental and clinical pharmacology; Pharmaceutical biology (pharmacognosy); Clinical pharmacy; History of pharmacy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信